PharmacyCodes



Apraclonidinum [Inn-Latin] en es it fr

Apraclonidinum [Inn-Latin] Brand names, Apraclonidinum [Inn-Latin] Analogs

Apraclonidinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Apraclonidinum [Inn-Latin] Chemical_Formula

C9H10Cl2N4

Apraclonidinum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic2/apraclonidine.htm

Apraclonidinum [Inn-Latin] fda sheet

Apraclonidinum_[Inn-Latin] FDA

Apraclonidinum [Inn-Latin] msds (material safety sheet)

Apraclonidinum_[Inn-Latin] MSDS

Apraclonidinum [Inn-Latin] Synthesis Reference

No information avaliable

Apraclonidinum [Inn-Latin] Molecular Weight

245.108 g/mol

Apraclonidinum [Inn-Latin] Melting Point

No information avaliable

Apraclonidinum [Inn-Latin] H2O Solubility

No information avaliable

Apraclonidinum [Inn-Latin] State

Solid

Apraclonidinum [Inn-Latin] LogP

1.53

Apraclonidinum [Inn-Latin] Dosage Forms

Liquid

Apraclonidinum [Inn-Latin] Indication

For short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional Intra Ocular Pressure (IOP) reduction.

Apraclonidinum [Inn-Latin] Pharmacology

Apraclonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.

Apraclonidinum [Inn-Latin] Absorption

No information avaliable

Apraclonidinum [Inn-Latin] side effects and Toxicity

No information avaliable

Apraclonidinum [Inn-Latin] Patient Information

No information avaliable

Apraclonidinum [Inn-Latin] Organisms Affected

Humans and other mammals